A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease

Summary

This study is to evaluate the safety and tolerability and to characterize the pharmacokinetics of multiple ascending dose (MAD) of LY03003 following intramuscular injections.

Timeline

Start

2017-10-10

Primary completion

2019-04-16

Completion

2019-06-21

Drugs

Indications